Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.

Ortonne JP, Khemis A, Koo JY, Choi J.

J Eur Acad Dermatol Venereol. 2005 Sep;19(5):556-63.

PMID:
16164708
4.

A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.

Lui H, Gulliver W, Tan J, Hong CH, Hull P, Shear NH, Paradiso-Hardy F, Bissonette R.

J Drugs Dermatol. 2012 Aug;11(8):929-37.

PMID:
22859237
5.

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group.

Arch Dermatol. 2003 Jun;139(6):719-27.

PMID:
12810502
6.

Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.

Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B.

Br J Dermatol. 2013 Jul;169(1):130-6. doi: 10.1111/bjd.12277.

PMID:
23834117
7.

Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.

Huang PH, Liao YH, Wei CC, Tseng YH, Ho JC, Tsai TF.

J Eur Acad Dermatol Venereol. 2008 Aug;22(8):923-30. doi: 10.1111/j.1468-3083.2007.02575.x. Epub 2008 Feb 27.

PMID:
18312328
8.

Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis.

Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, Kerl H, Wolf P.

Arch Dermatol. 2007 Aug;143(8):1016-22.

PMID:
17709660
9.

Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.

Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.

Br J Dermatol. 2011 Jun;164(6):1383-6. doi: 10.1111/j.1365-2133.2011.10358.x.

PMID:
21466532
10.

A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.

Krueger GG, Gottlieb AB, Sterry W, Korman N, Van De Kerkhof P.

J Dermatolog Treat. 2008;19(3):146-55. doi: 10.1080/09546630701846103.

PMID:
18569270
11.

Targeting T-cell subsets to achieve remission.

Christophers E.

J Eur Acad Dermatol Venereol. 2003 Jul;17 Suppl 2:6-11.

PMID:
12795769
12.

An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.

Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M.

J Am Acad Dermatol. 2005 Jul;53(1):73-5.

PMID:
15965424
13.

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group.

J Am Acad Dermatol. 2002 Dec;47(6):821-33.

PMID:
12451365
14.

A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.

Park KK, Wu JJ, Koo J.

J Eur Acad Dermatol Venereol. 2013 Jul;27(7):899-906. doi: 10.1111/j.1468-3083.2012.04611.x. Epub 2012 Jun 15.

PMID:
22702846
15.
16.
17.

Remittive effects of intramuscular alefacept in psoriasis.

Gordon KB, Langley RG.

J Drugs Dermatol. 2003 Dec;2(6):624-8.

PMID:
14711140
18.

Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.

Ring J, Kowalzick L, Christophers E, Schill WB, Schöpf E, Ständer M, Wolff HH, Altmeyer P.

Br J Dermatol. 2001 Mar;144(3):495-9.

PMID:
11260005
19.

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.

Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Yang YC, Chiou CF, Dann F, Stevens SR; Unite Study Group.

J Drugs Dermatol. 2008 Mar;7(3):245-53.

PMID:
18380206
20.

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

Ellis CN, Krueger GG; Alefacept Clinical Study Group.

N Engl J Med. 2001 Jul 26;345(4):248-55.

Supplemental Content

Support Center